Stay updated with breaking news from Active Ingredients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Reddy's Laboratories (NSE: DRREDDY), a leading global pharmaceutical company, recently announced strong financial performance for the latest quarter, demonstrating robust sales, profits, and free cash flow. The
/PRNewswire/ -- The "Global Opioid Induced Constipation Market by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel - Cumulative...
Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) has been given an average rating of “Hold” by the seven ratings firms that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating, one has issued a buy rating and one has […]
Dr. Reddy’s Laboratories (NYSE:RDY – Get Rating) had its price objective boosted by Barclays from $67.00 to $70.00 in a research note released on Thursday, The Fly reports. Several other research firms have also issued reports on RDY. StockNews.com began coverage on Dr. Reddy’s Laboratories in a report on Thursday, May 18th. They set a […]
Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating) has received a consensus rating of “Hold” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and one has given […]